4BASEBIO UK SOCIETAS
Research 4BASEBIO UK SOCIETAS (4BB) on Bullrun: market cap GBX 8.13B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4BB
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyGBX
- Market capGBX 8.13B
- Financial periodFY2024
- RevenueGBP 933.00K
- Revenue growth84.4%
- Net income-GBP 12.33M
- Free cash flow-GBP 12.32M
- Gross margin67.5%
Valuation Snapshot
latest market cap is GBX 8.13B.
About 4BASEBIO UK SOCIETAS
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA for in vitro transcription processes that produce mRNA for use in vaccines and therapeutics; oeDNA, a linear, double stranded DNA for genome editing;
Frequently asked questions
What is 4BASEBIO UK SOCIETAS's market cap?
4BASEBIO UK SOCIETAS's market capitalization is GBX 8.13B.
What does 4BASEBIO UK SOCIETAS do?
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications;